Business Context and Reporting Period
This Form 8-K filing by Landec Corporation (not Lifecore Biomedical, Inc.) reports on the Annual Meeting of Stockholders held on October 9, 2014. The filing details the voting results for three specific proposals submitted to security holders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting outcomes.
Material Changes and Voting Results
The following material events occurred during the meeting:
- Election of Directors: Four Class 1 directors were elected to two-year terms.
- Steven Goldby: 21,725,583 votes for (highest support).
- Catherine A. Sohn: 21,722,493 votes for.
- Gary T. Steele: 20,927,784 votes for.
- Frederick Frank: 20,608,193 votes for.
- Ratification of Auditors: Stockholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending May 31, 2015.
- Votes For: 24,177,654
- Votes Against: 1,290,024
- Abstentions: 5,593
- Executive Compensation: Stockholders approved the non-binding advisory proposal regarding executive compensation.
- Votes For: 21,276,690
- Votes Against: 452,210
- Abstentions: 209,416
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items. The document is limited to the reporting of past voting events.
Investor Verification Checklist
- Verify the correct registrant name is Landec Corporation, as the input metadata incorrectly referenced Lifecore Biomedical, Inc.
- Confirm the total number of shares represented at the meeting by summing votes for, against, abstentions, and broker non-votes.
- Review the full proxy statement for details on the specific compensation packages approved in the advisory vote.
- Check subsequent filings for the official appointment of the new Class 1 directors.